CMPX
NASDAQ · Biotechnology

Compass Therapeutics Inc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks
$5.44
+0.11 (+2.06%)
As of Mar 25, 2:01 PM ET ·
Analyst Consensus
Strong Buy
21
Analysts
High
Coverage
Buy 20 95%
Hold 1 5%
Sell 0 0%
Price Target
Analyst Price Target +888.4% upside
Low Target $36.32
Average Target $53.77
High Target $66.75
Current Price $5.44
Current
$5.44
Target
$53.77
$36.32 $53.77 avg $66.75
Scenario Analysis
Bear Case
$36.32
567.6%
Low target
Base Case
$53.77
+888.4%
Avg target
Bull Case
$66.75
+1,127.0%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$6.88
-20.9% from high
52-Week Low
$1.33
+309.0% from low
Target vs 52W High
$53.77
+681.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
 Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
 Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -27.6%